Suppr超能文献

血管活性肠肽(VIP)对雪貂气管黏液分泌的神经调节:大电导钙激活钾通道(BK(Ca))的激活及神经递质释放的抑制

Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release.

作者信息

Liu Y C, Patel H J, Khawaja A M, Belvisi M G, Rogers D F

机构信息

Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC.

出版信息

Br J Pharmacol. 1999 Jan;126(1):147-58. doi: 10.1038/sj.bjp.0702288.

Abstract
  1. The aims of this study were to determine: (1) whether vasoactive intestinal peptide (VIP) regulates cholinergic and 'sensory-efferent' (tachykininergic) 35SO4 labelled mucus output in ferret trachea in vitro, using a VIP antibody, (2) the class of potassium (K+) channel involved in VIP-regulation of cholinergic neural secretion using glibenclamide (an ATP-sensitive K+ (K(ATP)) channel inhibitor), iberiotoxin (a large conductance calcium activated K+ (BK(ca)) channel blocker), and apamin (a small conductance K(ca) (SK(ca)) channel blocker), and (3) the effect of VIP on cholinergic neurotransmission using [3H]-choline overflow as a marker for acetylcholine (ACh) release. 2. Exogenous VIP (1 and 10 microM) alone increased 35SO4 output by up to 53% above baseline, but suppressed (by up to 80% at 1 microM) cholinergic and tachykininergic neural secretion without altering secretion induced by ACh or substance P (1 microM each). Endogenous VIP accounted for the minor increase in non-adrenergic, non-cholinergic (NANC), non-tachykininergic neural secretion, which was compatible with the secretory response of exogenous VIP. 3. Iberiotoxin (3 microM), but not apamin (1 microM) or glibenclamide (0.1 microM), reversed the inhibition by VIP (10 nM) of cholinergic neural secretion. 4. Both endogenous VIP (by use of the VIP antibody; 1:500 dilution) and exogenous VIP (0.1 microM), the latter by 34%, inhibited ACh release from cholinergic nerve terminals and this suppression was completely reversed by iberiotoxin (0.1 microM). 5. We conclude that, in ferret trachea in vitro, endogenous VIP has dual activity whereby its small direct stimulatory action on mucus secretion is secondary to its marked regulation of cholinergic and tachykininergic neurogenic mucus secretion. Regulation is via inhibition of neurotransmitter release, consequent upon opening of BK(Ca) channels. In the context of neurogenic mucus secretion, we propose that VIP joins NO as a neurotransmitter of i-NANC nerves in ferret trachea.
摘要
  1. 本研究的目的是确定:(1) 使用血管活性肠肽 (VIP) 抗体,体外研究VIP是否调节雪貂气管中胆碱能和 “感觉-传出”(速激肽能)35SO4 标记的黏液分泌;(2) 使用格列本脲(一种ATP敏感性钾通道 (K(ATP)) 抑制剂)、iberiotoxin(一种大电导钙激活钾通道 (BK(ca)) 阻滞剂)和阿帕明(一种小电导钾通道 (SK(ca)) 阻滞剂),研究参与VIP调节胆碱能神经分泌的钾 (K+) 通道类型;(3) 以 [3H]-胆碱溢出作为乙酰胆碱 (ACh) 释放的标志物,研究VIP对胆碱能神经传递的影响。2. 单独使用外源性VIP(1和10 μM)可使35SO4 分泌量比基线水平增加高达53%,但抑制(在1 μM时高达80%)胆碱能和速激肽能神经分泌,而不改变由ACh或P物质(各1 μM)诱导的分泌。内源性VIP导致非肾上腺素能、非胆碱能(NANC)、非速激肽能神经分泌的轻微增加,这与外源性VIP的分泌反应一致。3. Iberiotoxin(3 μM)可逆转VIP(10 nM)对胆碱能神经分泌的抑制作用,而阿帕明(1 μM)或格列本脲(0.1 μM)则不能。4. 内源性VIP(使用VIP抗体;1:500稀释)和外源性VIP(0.1 μM)均抑制胆碱能神经末梢释放ACh,后者抑制率为34%,且这种抑制作用可被iberiotoxin(0.1 μM)完全逆转。5. 我们得出结论,在体外雪貂气管中,内源性VIP具有双重活性,其对黏液分泌的微小直接刺激作用继发于其对胆碱能和速激肽能神经源性黏液分泌的显著调节。调节是通过BK(Ca) 通道开放后抑制神经递质释放来实现的。在神经源性黏液分泌的背景下,我们提出VIP与一氧化氮一样,是雪貂气管中i-NANC神经的神经递质。

相似文献

引用本文的文献

4
Mucus secretion from individual submucosal glands of the ferret trachea.从雪貂气管的单个黏膜下腺分泌黏液。
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L124-36. doi: 10.1152/ajplung.00049.2010. Epub 2010 Apr 30.

本文引用的文献

7
Neuroregulation of the nose and bronchi.鼻与支气管的神经调节
Clin Exp Allergy. 1996 May;26 Suppl 3:32-5. doi: 10.1111/j.1365-2222.1996.tb00656.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验